U.S. Markets closed

Strength Seen in GTX (GTXI): Stock Moves 8.8% Higher

Zacks Equity Research

GTX Inc. (GTXI) was a big mover last session with shares rising nearly 9% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading way above the past one month’s volatile price range of $1.68 to $1.84.

This biopharmaceutical company has seen no estimate revision in the last 30 days. The Zacks Consensus Estimate hasn’t been in trend either. Yesterday’s rally is encouraging though, so make sure to keep a close watch on this firm in the near future.

GTX currently holds a Zacks Rank #3 (Hold) while its Earnings ESP is positive.

Investors interested in the biomedical industry may consider better-ranked stocks like Alexion Pharmaceuticals, Inc. (ALXN), Gilead Sciences Inc. (GILD) and Actelion Ltd. (ALIOF). While ALXN and GILD sport a Zacks Rank #1 (Strong Buy), ALIOF bears a Zacks Rank #2 (Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

GTX INC (GTXI): Free Stock Analysis Report


GILEAD SCIENCES INC (GILD): Free Stock Analysis Report

ACTELION LTD (ALIOF): Free Stock Analysis Report

Zacks Investment Research